Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, Ireland, April 07, 2021 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, today announced that in connection with hiring Dr. Hideki Garren as Prothena’s Chief Medical Officer, the […] Lire la suite »

PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system

RALEIGH, N.C. , April 07, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA’s remote patient monitoring platform to work in combination with its human growth hormone (HGH) treatment system. Under this agreement, […] Lire la suite »

ASSYSTEM: Publication du document d’enregistrement universel 2020

                   Publication du document d’enregistrement universel 2020 Paris-La Défense, le 7 avril 2020 à 17h35 – Assystem S.A. (ISIN : FR0000074148 – ASY), annonce que son document d’enregistrement universel 2020 a été déposé aujourd’hui auprès de l’Autorité des marchés financiers. Il est tenu gratuitement à la disposition du public dans […] Lire la suite »

AIM ImmunoTech Announces Positive Safety Data in First Cohort of Phase 1 Clinical Study Investigating Intranasal Administration of Ampligen as a Potential Prophylaxis or Treatment for COVID-19 and Other Respiratory Viral Diseases

OCALA, Fla., April 07, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has completed dosing of Cohort 1 in a Phase 1 clinical study on the safety of AIM’s drug Ampligen as an intranasal therapy, reporting no serious adverse events, and paving the way […] Lire la suite »

Olympus Announces Global Image of the Year Award Winners

WALTHAM, Mass., April 07, 2021 (GLOBE NEWSWIRE) — Olympus unveiled the winners of their second Global Image of the Year Life Science Light Microscopy Award, an annual competition that recognizes the best in life science imaging. The winning images were selected from a record number of entries—nearly 700 submissions from […] Lire la suite »

Morgan Stanley Europe SE: Stabilisation Notice

FRANKFURT, Germany, April 07, 2021 (GLOBE NEWSWIRE) — Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CTP NV Mid-stabilisation Period Announcement Morgan Stanley Europe SE acting as Stabilisation Manager (contact: (James Manson-Bahr; telephone: +49 69 2166 1281) […] Lire la suite »

ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma

IRVINE, Calif., April 07, 2021 (GLOBE NEWSWIRE) — ERC-USA and the University of California, Irvine (UCI), today announce that the FDA has recommended early termination of the onging Phase 2 clinical trial titled ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma in a letter dated April 2, 2021 ( The FDA further […] Lire la suite »

Rackspace Technology kündigt virtuellen runden Tisch an: What Your Cloud Strategy May Be Overlooking

SAN ANTONIO, April 07, 2021 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT), ein führendes Unternehmen für End-to-End-Multi-Cloud-Technologie-Lösungen präsentiert am 12. April um 10:00 Uhr (Central Time) einen virtuellen runden Tisch zum Thema What Your Cloud Strategy May Be Overlooking. In seiner Keynote-Präsentation rückt Gastredner Bill Martorelli von Forrester einige Mythen […] Lire la suite »

First Quantum Provides Notice of First Quarter 2021 Results

TORONTO, April 07, 2021 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“FQM” or the “Company”) (TSX: FM) will release first quarter 2021 financial and operating results on Tuesday, April 27, 2021 after the close of the Toronto Stock Exchange. The Company will host a conference call and webcast to discuss […] Lire la suite »

The European Commission Grants Marketing Authorization for New Subcutaneous Administration of TYSABRI® (natalizumab) to Treat Relapsing-Remitting Multiple Sclerosis

TYSABRI is a well-established high-efficacy treatment that now provides two routes of administration enabling flexibility to meet patients’ individual preferences and needs The subcutaneous option provides a shorter administration time and expands access to treatment for patients and physicians beyond the infusion setting The approval adds to Biogen’s strong MS […] Lire la suite »

BRYTER sammelt 66 Millionen USD in Serie B Finanzierungsrunde ein

LONDON und NEW YORK und BERLIN, April 07, 2021 (GLOBE NEWSWIRE) — BRYTER, die No Code-Service-Automatisierungsplattform, hat eine 66 Millionen Dollar schwere Finanzierungsrunde der Serie B erfolgreich abgeschlossen. Mit der neuerlichen Kapitalerhöhung, die nur 8 Monate nach der Serie A Finanzierungsrunde erfolgte, erhöht sich das bisher eingeworbene Kapital auf insgesamt […] Lire la suite »

Slalom invests in UK growth, plans to add nearly 100 jobs in 2021

LONDON, April 07, 2021 (GLOBE NEWSWIRE) — Slalom, the modern consulting firm focused on strategy, technology, and business transformation, today announced a plan to significantly expand its United Kingdom presence in 2021 and beyond. With offices in London and Manchester, Slalom will add nearly 100 product development, experience design, data, […] Lire la suite »